|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
IL105456A
(en)
|
1992-04-21 |
1996-12-05 |
American Home Prod |
Vaccines of attenuated respiratory syncytial virus
|
|
AT401526B
(de)
|
1993-02-10 |
1996-09-25 |
Scheirer Winfried |
Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung
|
|
ATE257175T1
(de)
|
1994-07-18 |
2004-01-15 |
Conzelmann Karl Klaus Prof Dr |
Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
|
|
US7465574B2
(en)
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
|
US6264957B1
(en)
|
1995-09-27 |
2001-07-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Product of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US6923971B2
(en)
|
1995-09-27 |
2005-08-02 |
The United States Of America As Represented By The Department Of Health & Human Services |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
|
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
|
US6713066B1
(en)
|
1996-07-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
|
US6214805B1
(en)
|
1996-02-15 |
2001-04-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
RNase L activators and antisense oligonucleotides effective to treat RSV infections
|
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
|
WO1998002530A1
(en)
|
1996-07-15 |
1998-01-22 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
US6074859A
(en)
|
1997-07-08 |
2000-06-13 |
Kikkoman Corporation |
Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
|
|
US20040005542A1
(en)
|
2001-06-22 |
2004-01-08 |
Krempl Christine D |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
|
|
US20020018780A1
(en)
*
|
2000-05-25 |
2002-02-14 |
Scott Koenig |
Epitope-based vaccine for respiratory syncytial virus F-protein
|
|
EP1613345B1
(en)
|
2003-03-28 |
2010-05-26 |
MedImmune, LLC |
Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
|
|
PT1699919T
(pt)
|
2003-12-24 |
2017-04-03 |
De Staat Der Nederlanden Vertegenwoordigd Door De Mini Van Volksgezondheid Welzijn En Sport |
Um vírus sincicial respiratório com deficiência genómica complementada em trans
|
|
CA2587084C
(en)
|
2004-10-08 |
2019-07-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Modulation of replicative fitness by using less frequently used synonym ous codons
|
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
WO2008133663A2
(en)
|
2006-11-30 |
2008-11-06 |
Government Of The United States Of America, As Represented By The Secretary, |
Codon modified immunogenic compositions and methods of use
|
|
KR101621100B1
(ko)
|
2007-03-30 |
2016-05-13 |
더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 |
백신에 유용한 약독화 바이러스
|
|
US8580270B2
(en)
|
2008-09-30 |
2013-11-12 |
University Of Massachusetts |
Respiratory synctial virus (RSV) sequences for protein expression and vaccines
|
|
US9011876B2
(en)
|
2008-11-05 |
2015-04-21 |
Merck Sharp & Dohme Corp. |
Live, attenuated respiratory syncytial virus
|
|
PL2370099T3
(pl)
|
2008-12-09 |
2016-10-31 |
|
Zmodyfikowane białka F RSV i sposoby ich zastosowania
|
|
CA2768186A1
(en)
|
2009-07-15 |
2011-01-20 |
Novartis Ag |
Rsv f protein compositions and methods for making same
|
|
US20110097358A1
(en)
|
2009-10-12 |
2011-04-28 |
Techno Vax, Inc. |
RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
|
|
US10227569B2
(en)
|
2011-04-12 |
2019-03-12 |
Emory University |
Respiratory syncytial virus expression vectors
|
|
CA2835644C
(en)
*
|
2011-05-13 |
2021-06-15 |
Novartis Ag |
Pre-fusion rsv f antigens
|
|
EP2729169A1
(en)
|
2011-07-06 |
2014-05-14 |
Nanobio Corporation |
Human respiratory syncytial virus vaccine
|
|
US8816081B2
(en)
|
2012-08-06 |
2014-08-26 |
Basf Se |
Boron containing perylene monoimides, a process for their production, their use as building blocks for the production of perylene monoimide derivatives, monoimide derivatives and their use in dye-sensitized solar cells
|
|
EP4190895A1
(en)
|
2013-02-08 |
2023-06-07 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
|
|
EP2970398B1
(en)
*
|
2013-03-13 |
2024-05-08 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services |
Prefusion rsv f proteins and their use
|
|
US9738689B2
(en)
*
|
2013-03-13 |
2017-08-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion RSV F proteins and their use
|
|
EP3798310A1
(en)
|
2013-03-14 |
2021-03-31 |
Emory University |
Recombinant rsv with silent mutations, vaccines, and methods related thereto
|
|
US9060975B2
(en)
*
|
2013-03-14 |
2015-06-23 |
Mucosis Bv |
Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions
|